Booth Mark D

Chief Commercial Officer at Orexigen Therapeutics, Inc.

Sold, on record
$1.7M
Dollars the filings state
Form 4 sales
5
Latest Feb 26, 2015
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Jun 28, 2012 2012

    Sold 103,309 shares at $5.66 ($585k)

    Booth Mark D, Chief Commercial Officer

    Sold 100% of holdings ($585k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Jan 15, 2013 +201 days

    Sold 22,315 shares at $6.67 ($149k)

    Booth Mark D, Chief Commercial Officer

    Sold 100% of holdings ($149k position)0 shares leftFiling

  3. 3 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Mar 11, 2013 +55 days

    Sold 27,685 shares at $6.67 ($185k)

    Booth Mark D, Chief Commercial Officer

    Sold 100% of holdings ($185k position)0 shares leftFiling

  4. 4 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Jul 26, 2013 +137 days

    Sold 64,767 shares at $7.55 ($489k)

    Booth Mark D, Chief Commercial Officer

    Sold 100% of holdings ($489k position)0 shares left2.3x usual sizeFiling

  5. 5 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Feb 26, 2015 +580 days

    Sold 50,000 shares at $5.68 ($284k)

    Booth Mark D, Chief Commercial Officer

    Sold 92.9% of holdings ($306k position)3,810 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Booth Mark D
Source
Feb 26, 2015Mar 2, 2015Orexigen Therapeutics, Inc.Chief Commercial OfficerForm 4 sale50,000$284k92.9%UnusualSEC
Jul 26, 2013Jul 29, 2013Orexigen Therapeutics, Inc.Chief Commercial OfficerForm 4 sale64,767$489k100.0%UnusualSEC
Mar 11, 2013Mar 12, 2013Orexigen Therapeutics, Inc.Chief Commercial OfficerForm 4 sale27,685$185k100.0%UnusualSEC
Jan 15, 2013Jan 18, 2013Orexigen Therapeutics, Inc.Chief Commercial OfficerForm 4 sale22,315$149k100.0%UnusualSEC
Jun 28, 2012Jun 29, 2012Orexigen Therapeutics, Inc.Chief Commercial OfficerForm 4 sale103,309$585k100.0%UnusualSEC